CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

Pokaži ostale verzije (1)

Bibliografski detalji
Glavni autori:	Guang Wang, Juan Fu, Mulin Liu, Qin Zheng
Format:	Članak
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2024-01-01
Serija:	PLoS ONE
Online pristup:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI

Slični predmeti

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
od: Guang Wang, i dr.
Izdano: (2024-01-01)

The Role of CXC Chemokines in Cardiovascular Diseases
od: Xiyi Lu, i dr.
Izdano: (2022-05-01)

FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
od: N. V. Kipich, i dr.
Izdano: (2014-07-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
od: Tesfaye Wolde, i dr.
Izdano: (2024-02-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
od: GhH Hassanshahiraviz, i dr.
Izdano: (2005-03-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
od: GhH Hassanshahiraviz, i dr.
Izdano: (2005-10-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
od: Li-Peng Pei, i dr.
Izdano: (2022-06-01)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
od: Li D, i dr.
Izdano: (2021-09-01)

The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain.
od: Anthony, D, i dr.
Izdano: (1999)

CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
od: Kayode Komolafe, i dr.
Izdano: (2022-01-01)

Biophysical characterization of the CXC chemokine receptor 2 ligands
od: Patrick Martin, i dr.
Izdano: (2024-01-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
od: Jianming Tang, i dr.
Izdano: (2022-08-01)

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
od: Valentina Brancato, i dr.
Izdano: (2024-12-01)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
od: Munan Zhao, i dr.
Izdano: (2023-01-01)

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma
od: Liang Ma, i dr.
Izdano: (2025-01-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
od: Na Wu, i dr.
Izdano: (2025-02-01)

Key wound healing genes as diagnostic biomarkers and therapeutic targets in uterine corpus endometrial carcinoma: an integrated in silico and in vitro study
od: Fuchuan Jiang, i dr.
Izdano: (2025-01-01)

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
od: Mehrnaz Gharaee-Kermani, i dr.
Izdano: (2012-01-01)

The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.
od: Sallouha Aidoudi, i dr.
Izdano: (2008-01-01)

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma
od: Xiaoxuan Tang, i dr.
Izdano: (2025-02-01)

RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma
od: Rong Geng, i dr.
Izdano: (2020-11-01)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
od: Fang Zhang, i dr.
Izdano: (2023-02-01)

Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis
od: Erbao Chen, i dr.
Izdano: (2018-02-01)

A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer
od: Hossein Hozhabri, i dr.
Izdano: (2022-06-01)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
od: Zhiheng Lin, i dr.
Izdano: (2022-09-01)

Identification of CAPG as a potential prognostic biomarker associated with immune cell infiltration and ferroptosis in uterine corpus endometrial carcinoma
od: Junwei Liu, i dr.
Izdano: (2024-11-01)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
od: Ling Zhao, i dr.
Izdano: (2021-01-01)

Exploring Chemokine Homodimer Stability: Structural Insights into CXC and CC Interfaces
od: David Budean, i dr.
Izdano: (2024-11-01)

Structural basis of CXC chemokine receptor 1 ligand binding and activation
od: Naito Ishimoto, i dr.
Izdano: (2023-07-01)

Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts.
od: Yuichi Yashiro, i dr.
Izdano: (2014-01-01)

CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration.
od: Gregory C Wilson, i dr.
Izdano: (2015-01-01)

Prognostic Significance and Immune Cell Infiltration Analysis of CXC Chemokines in Glioblastoma
od: LIU Fangyuan, i dr.
Izdano: (2021-04-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
od: Kang He, i dr.
Izdano: (2023-01-01)

UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion
od: Sijia Ma, i dr.
Izdano: (2023-10-01)

Risk prediction model of uterine corpus endometrial carcinoma based on immune-related genes
od: Qiu Sang, i dr.
Izdano: (2024-07-01)

Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.
od: Tony Ngo, i dr.
Izdano: (2020-04-01)

A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma
od: Jiaxing Wang, i dr.
Izdano: (2024-10-01)

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
od: Qi Zhang, i dr.
Izdano: (2024-02-01)

Cloning and bioactivity analysis of a CXC ligand in black seabream <it>Acanthopagrus schlegeli</it>: the evolutionary clues of ELR<sup>+</sup>CXC chemokines
od: Kezhi Xing, i dr.
Izdano: (2008-11-01)

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics
od: Jing Liu, i dr.
Izdano: (2024-07-01)